Heikki Peltola
Children's Hospital
Helsinki University Central Hospital
Helsinki
Finland
Name/email consistency: high
- Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood--a prospective quasi-randomized controlled trial. Peltola, H., Pääkkönen, M., Kallio, P., Kallio, M.J. Clin. Microbiol. Infect. (2012)
- Naturally fluctuating low incidence of invasive pneumococcal infections not affected by large-scale haemophilus influenzae type B vaccination. Peltola, H., Helminen, M., Vuento, R. Pediatr. Infect. Dis. J. (2010)
- Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol. Peltola, H., Roine, I., Fernández, J., González Mata, A., Zavala, I., Gonzalez Ayala, S., Arbo, A., Bologna, R., Goyo, J., López, E., Miño, G., Dourado de Andrade, S., Sarna, S., Jauhiainen, T. Pediatrics (2010)
- Diagnosis of Streptococcus pneumoniae and Haemophilus influenzae type b meningitis by identifying DNA from cerebrospinal fluid-impregnated filter paper strips. Peltola, H., Roine, I., Leinonen, M., Kuisma, L., Mata, A.G., Arbo, A., Goyo, J., Saukkoriipi, A. Pediatr. Infect. Dis. J. (2010)
- Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positive cases. Peltola, H., Pääkkönen, M., Kallio, P., Kallio, M.J. Pediatr. Infect. Dis. J. (2010)
- Improving the outcomes in children with bacterial meningitis. Peltola, H., Roine, I. Curr. Opin. Infect. Dis. (2009)
- Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis. Peltola, H., Pääkkönen, M., Kallio, P., Kallio, M.J. Clin. Infect. Dis. (2009)
- Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme. Peltola, H., Jokinen, S., Paunio, M., Hovi, T., Davidkin, I. Lancet. Infect. Dis (2008)
- Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Peltola, H., Roine, I., Fernández, J., Zavala, I., Ayala, S.G., Mata, A.G., Arbo, A., Bologna, R., Miño, G., Goyo, J., López, E., de Andrade, S.D., Sarna, S. Clin. Infect. Dis. (2007)
- Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Peltola, H., Kulkarni, P.S., Kapre, S.V., Paunio, M., Jadhav, S.S., Dhere, R.M. Clin. Infect. Dis. (2007)
- Incidence of Haemophilus influenzae type b meningitis during 18 years of vaccine use: observational study using routine hospital data. Peltola, H., Salo, E., Saxén, H. BMJ (2005)
- Pneumococcal conjugate vaccine for acute otitis media--yes or no?. Peltola, H., Schmitt, J., Booy, R. Lancet (2003)
- Burden of meningitis and other severe bacterial infections of children in africa: implications for prevention. Peltola, H. Clin. Infect. Dis. (2001)
- Successful shortening from seven to four days of parenteral beta-lactam treatment for common childhood infections: a prospective and randomized study. Peltola, H., Vuori-Holopainen, E., Kallio, M.J. Int. J. Infect. Dis. (2001)
- Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Peltola, H. Clin. Microbiol. Rev. (2000)
- Mumps and rubella eliminated from Finland. Peltola, H., Davidkin, I., Paunio, M., Valle, M., Leinikki, P., Heinonen, O.P. JAMA (2000)
- What would happen if we stopped vaccination?. Peltola, H. Lancet (2000)
